List of works - Luigi F Meneghini

"Will I have to be on insulin for the rest of my life?": Introduction

scientific article published on 01 April 2010

A pragmatic randomized clinical trial of insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of ACHIEVE Control

scientific article published on 30 July 2020

A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study

scientific article published on 28 June 2019

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

scientific article published on 10 September 2018

Bariatric intervention effective at reversing Type 2 diabetes

scientific article published on 25 August 2012

Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.

scientific article

Clarification of the similarities and differences among insulin analog preparations: response to Becker

scientific article published on 01 February 2008

Clinical use of insulin degludec.

scientific article published on 14 April 2015

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.

scientific article published on 01 February 2019

Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study

scientific article published in September 2011

Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial

scientific article published on 01 June 2007

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

scientific article

How good is your glucose control?

scientific article

Hypoglycaemia and treatment patterns among insulin-treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real-world setting

scientific article published on 14 June 2019

Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes

scientific article

Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study

scientific article published on 04 September 2020

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

scientific article published in July 2010

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin

scientific article published on 28 November 2019

Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomised, pragmatic real-life clinical trial

scientific article published on 15 June 2020

Insulin stacking versus therapeutic accumulation: understanding the differences.

scientific article published on January 2014

Insulin therapy for type 2 diabetes

scientific article published on 27 October 2012

Intensifying insulin therapy: what options are available to patients with type 2 diabetes?

scientific article published on September 2013

More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L

scientific article published on 13 June 2018

Multilevel Variation in Diabetes Screening Within an Integrated Health System

scientific article published on 05 March 2020

Obesity, bariatric surgery and type 2 diabetes--a systematic review

scientific article published in November 2004

Physician survey on pre-/postprocedure measures for injectable treatments

scientific article published on 01 August 2020

Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.

scientific article published on June 2010

Practical guidance to insulin management

scientific article published on April 2010

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.

scientific article

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study

scientific article published on 14 February 2019

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiated on basal insulin.

scientific article

Role of Devices in Insulin Delivery.

scientific article

Screening, evaluation and management of depression in people with diabetes in primary care

scientific article published on 30 December 2012

Stepwise addition of prandial insulin

scientific article published on 25 September 2013

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting

scientific article published on 28 March 2019

The association of hypoglycaemia severity and clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.

scientific article published on 5 January 2018

Towards a better understanding of postprandial hyperglycemic episodes in people with diabetes: impact on daily functioning

scientific article published on 09 November 2018

List of works by Luigi F Meneghini

"Will I have to be on insulin for the rest of my life?": Introduction

A pragmatic randomized clinical trial of insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of ACHIEVE Control

A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: The SIMPLE study

Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis

Bariatric intervention effective at reversing Type 2 diabetes

Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities.

Clarification of the similarities and differences among insulin analog preparations: response to Becker

Clinical use of insulin degludec.

Commencing insulin glargine 100 U/mL therapy in individuals with type 2 diabetes: Determinants of achievement of HbA1c goal less than 7.0.

Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study

Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial

Efficacy and Safety of Insulin Glargine 300 U/mL Versus Insulin Glargine 100 U/mL in High-Risk and Low-Risk Patients with Type 2 Diabetes Stratified Using Common Clinical Performance Measures

How good is your glucose control?

Hypoglycaemia and treatment patterns among insulin-treated patients with type 2 diabetes who switched to insulin glargine 300 units/mL versus other basal insulin in a real-world setting

Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes

Impact of Quality Improvement (QI) Program on 5-Year Risk of Diabetes-Related Complications: A Simulation Study

Improved glycemic control with insulin glargine versus pioglitazone as add-on therapy to sulfonylurea or metformin in patients with uncontrolled type 2 diabetes mellitus.

Insulin degludec/liraglutide (IDegLira) maintains glycaemic control and improves clinical outcomes, regardless of pre-trial insulin dose, in people with type 2 diabetes that is uncontrolled on basal insulin

Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomised, pragmatic real-life clinical trial

Insulin stacking versus therapeutic accumulation: understanding the differences.

Insulin therapy for type 2 diabetes

Intensifying insulin therapy: what options are available to patients with type 2 diabetes?

More patients reach glycaemic control with a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) than with basal insulin at 12 weeks of treatment: A post hoc time-to-control analysis of LixiLan-O and LixiLan-L

Multilevel Variation in Diabetes Screening Within an Integrated Health System

Obesity, bariatric surgery and type 2 diabetes--a systematic review

Physician survey on pre-/postprocedure measures for injectable treatments

Practical aspects and considerations when switching between continuous subcutaneous insulin infusion and multiple daily injections.

Practical guidance to insulin management

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.

Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study

Relationship between treatment persistence and A1C trends among patients with type 2 diabetes newly initiated on basal insulin.

Role of Devices in Insulin Delivery.

Screening, evaluation and management of depression in people with diabetes in primary care

Stepwise addition of prandial insulin

The Diabetes Unmet Need with Basal Insulin Evaluation (DUNE) study in type 2 diabetes: Achieving HbA1c targets with basal insulin in a real-world setting

The association of hypoglycaemia severity and clinical, patient-reported and economic outcomes in US patients with type 2 diabetes using basal insulin.

Towards a better understanding of postprandial hyperglycemic episodes in people with diabetes: impact on daily functioning